A mitochondrially-derived peptide owned by $CWBR recently shown to abate completely any toxicity to cultured neuronal cells conferred by amyloid proteins. And at low therapeutic concentration. Next step: animal model guessing this will be announced after Nasdaq uplist in a couple weeks.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.